All Insights
Showing 613 - 624 of 1927
Regulatory and compliance
Commission proposes one-year delay to the implementation of the EU Deforestation Regulation
Following numerous calls for postponement, a 12-month delay to implementation has been proposed
Regulatory and compliance
UK government launches the Regulatory Innovation Office
RIO will support innovative businesses in fast-growth sectors by speeding up regulatory approval and cutting 'red tape'
Financial Services
New bill and case law clarify path forward for digital assets in the UK
Recognition of digital assets as personal property comes crucially as investors' court claims test the edges of the law
Life Sciences and Healthcare
European Medicines Agency issues guidance on AI use in pharma regulatory science
The drug agency's new guidance focuses on regulatory authorities but holds relevance for the industry
Financial Services
What practical issues are holding back green consumer finance in the UK?
Robust consumer protections for unsecured lending can pose problems, while mortgages are far from a perfect solution
Regulatory Outlook
Sanctions and Export Control | UK Regulatory Outlook October 2024
Office of Trade Sanctions Implementation launch | G7 issues guidance for industry on preventing Russian export controls and sanctions evasion
Financial Services
FCA gives clear message to UK firms: the Consumer Duty journey is only just 'beginning'
With the new regime now fully in force since 31 July, what approach can firms expect from the financial regulator?
Life Sciences and Healthcare
Belgium advances digital health as its Parliament calls for action
The government has been urged to prioritise accessible and affordable digital health solutions
The Built Environment
The Grenfell Tower Inquiry Phase 2 Report and its potential impact on UK regulation of the built environment
What might the report's damning criticisms and recommendations mean for industry?
Financial Services
What's holding back UK green consumer finance? A financial services perspective
What is green finance, why is it needed and what are the challenges?
Financial Services
AIFMD II: what Europe's fund managers need to know about the new loan origination regime
New requirements will regulate EEA alternative investment fund managers' loan origination activities
Life Sciences and Healthcare
Draghi report on EU competitiveness offers new recommendations for pharma and biotech
The former European central banker's report delivers strategic insights for pharma companies doing business in the EU
